BridgeMD
The effect of additional pre-extubational loading dose of caffeine-citrate
EU CTIS ID: 2024-519041-29-02
What this study is testing
Our objective was to investigate wether an additional pre extubational loading dose of caffeine-citrate change the extubation success rate.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Preterm neonates born before the 32nd week of gestation and had been mechanicaly ventillated for at least 48 hours. Before the first planned extubation.
You likely can't join if
- Lack of consent. Preterm neonate with major congenital anomaly. Did not recieved surfactant therapy. Hydrops foetalis. Persistent tachycardia prior to extubation, foetal/neonatal arrhytmia. Asphyxia.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.